Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001190976 | SCV001358645 | likely benign | Cardiomyopathy | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365883 | SCV002657380 | likely benign | Cardiovascular phenotype | 2022-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003770149 | SCV004620270 | likely benign | Hypertrophic cardiomyopathy | 2022-12-16 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003770149 | SCV005430072 | likely benign | Hypertrophic cardiomyopathy | 2024-06-09 | criteria provided, single submitter | clinical testing |